Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  70478-01 Organochlorine Exposure and Breast Cancer Risk End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
70478-01 Organochlorine Exposure and Breast Cancer Risk



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 70478-01 ORGANOCHLORINE EXPOSURE AND BREAST CANCER RISK

  3. Project Focus: EXPOSURE ASSESSMENT

  4. Description: Recently, associations have been found between breast cancer risk and organochlorine exposures as estimated fromblood and tissue levels of residues. Therefore, organochlorine exposures may contribute to the high breast cancer ratesin the U.S. Several organochlorines such as DDT, PCB mixtures, and several PCB congeners have considerableestrogenic activity. Endogenous estrogens are well established breast cancer risk factors, and timing and duration ofexposure is critical. This application addresses the hypothesis that exposure to estrogenic organochlorines enhancesbreast cancer development. Possible enhancing effects on breast carcinogenesis of estrogenic organochlorine exposuremay be most profound when endogenous estrogen production is low (before puberty or postmenopausal). To test thishypothesis, the MNU mammary carcinogenesis model system in the Sprague Dawley rat will be used to examine theinfluence on mammary cancer development of well controlled exposure during specific time periods to the estrogenicDDT isomer o,p-DDT and an estrogenic PCB mixture Aroclor 1221. Thus, it will be determined whether theseorganochlorines modify mammary cancer induction when administered at the following times: (1) from 2 weeks after thecarcinogen ("promotion" stage); (2) subsequent to surgically-induced menopause as surrogate for menopause in women("post-ovariectomy" stage); and (3) from weaning (3 weeks of age) until carcinogen injection ("pre- initiation" stage). Toachieve aim 3, it will be necessary to compensate for possible organochlorine-induced shifts in the timing of cellproliferation during puberty which is a critical element of the single carcinogen dose mammary carcinogenesis model inthe rat. Therefore, changes in the time of occurrence of cell proliferation in the cellular target of carcinogens in thedeveloping mammary gland (the terminal end-bud) will be determined with respect to organochlorine exposure duringthe pre initiation and perinatal stages. The results of these studies will demonstrate the mammary carcinogenesis-enhancing potential of estrogenic organochlorines, and they will establish differential effects of exposure at critical timesduring development and aging in relation to environmental mammary carcinogenesis.

  5. References:

  6. Category: MODELS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: MAMMALIAN, LABORATORY STUDY

  9. Keywords for Experimental Endpoints: CARCINOGENESIS, PUBERTY, TISSUE RESIDUE, RISK FACTORS

  10. Chemical Agents: AROCHLOR 1221, PCB, o,p-DDT

  11. Performing Institution: NEW YORK UNIVERSITY

  12. Contact: CONTACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301- 496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer